Ki Young Jang,Mijin Park,Kyeong Soo Kim,Yong Il Kim,Jae Hyun Park,Jong Soo Woo
申请号：
US13637530
公开号：
US20130022684A1
申请日:
2011.04.12
申请国别(地区):
US
年份:
2013
代理人:
摘要：
An oral pharmaceutical composition of the present invention comprising fenofibric acid or a pharmaceutically acceptable salt thereof, and 0.22 to 1 part by weight of an alkalifying agent based on 1 part by weight of fenofibric acid has improved bioavailability and a minimized absorption deviation in the gastrointestinal tract, which is useful in treating hyperlipidemia and hypertriglyceridemia.
